Skip to main content
. 2020 Jan;18(1):5–14. doi: 10.1370/afm.2461

Table 2.

Adherence to Controller Inhalers at Baseline and 9 Months, by Study Arm (N = 98)

Measure Health-Coaching Arm (n = 50)
Usual-Care Arm (n = 48)
Difference, % Adjusted Difference, % (95% CI)a P Value
Baseline 9 Months Baseline 9 Months
Number days (of the last 7) patient reported taking medications as prescribed, mean (SD) 5.9 (2.0) 6.4 (1.3) 5.6 (2.4) 5.5 (2.0) 0.84 0.75 (0.13 to 1.37) .02
Perfect adherence, % (No.) 66.0 (33) 70.0 (35) 58.3 (28) 54.2 (26) 15.8 15.2 (–4.3 to 34.8) .13
Good adherence, % (No.) 84.0 (42) 90.0 (45) 79.2 (38) 68.8 (33) 21.2 26.4 (6.9 to 49.9) .008
a

Adjusted for baseline value of measure and clustering by clinic site.

Note: Includes only patients with data for baseline and 9 months (ie, patients on controller inhalers at both time points). See Table 1 footnotes for definitions of adherence.